Literature DB >> 25109512

Cardiopulmonary reserve as determined by cardiopulmonary exercise testing correlates with length of stay and predicts complications after radical cystectomy.

Stephen Tolchard1, Johanna Angell, Mark Pyke, Simon Lewis, Nicholas Dodds, Alia Darweish, Paul White, David Gillatt.   

Abstract

OBJECTIVE: To investigate whether poor preoperative cardiopulmonary reserve and comorbid state dictate high-risk status and can predict complications in patients undergoing radical cystectomy (RC). PATIENTS AND METHODS: In all, 105 consecutive patients with transitional cell carcinoma (TCC; stage T1-T3) undergoing robot-assisted (38 patients) or open (67) RC in a single UK centre underwent preoperative cardiopulmonary exercise testing (CPET). Prospective primary outcome variables were all-cause complications and postoperative length of stay (LOS). Binary logistic regression analysis identified potential predictive factor(s) and the predictive accuracy of CPET for all-cause complications was examined using receiver operator characteristic (ROC) curve analysis. Correlations analysis employed Spearman's rank correlation and group comparison, the Mann-Whitney U-test and Fisher's exact test. Any relationships were confirmed using the Mantel-Haenszel common odds ratio estimate, Kaplan-Meier analysis and the chi-squared test.
RESULTS: The anaerobic threshold (AT) was negatively (r = -206, P = 0.035), and the ventilatory equivalent for carbon dioxide (VE/VCO₂) positively (r = 0.324, P = 0.001) correlated with complications and LOS. Logistic regression analysis identified low AT (<11 mL/kg/min), high VE/VC0₂ (≥33) and hypertension as significant factors, such that, in their presence patients were 5.55-times more likely to have complications at 90 days postoperatively [P = 0.001, 95% confidence interval (CI) 2.2-13.9]. ROC analysis showed a high significance (area under the curve 0.78, 95% CI 0.69-0.87; P < 0.001). In addition, based on CPET criteria >50% of patients presenting for RC had significant heart failure, whereas preoperatively only very few (2%) had this diagnosis. Analysis using the Mann-Whitney test showed that a VE/VCO₂ ≥33 was the most significant determinant of LOS (P = 0.004). Kaplan-Meier analysis showed that patients in this group had an additional median LOS of 4 days (P = 0.008). Finally, patients with an American Society of Anesthesiologists grade of 3 (ASA 3) and those on long-term β-blocker therapy were found to be at particular risk of myocardial infarction (MI) and death after RC with odds ratios of 4.0 (95% CI 1.05-15.2; P = 0.042) and 6.3 (95% CI 1.60-24.8; P = 0.008).
CONCLUSION: Patients with poor cardiopulmonary reserve and hypertension are at higher risk of postoperative complications and have increased LOS after RC. Heart failure is known to be a significant determinant of perioperative death and is significantly under diagnosed in this patient group.
© 2014 The Authors. BJU International © 2014 BJU International.

Entities:  

Keywords:  anaerobic threshold; cardiopulmonary exercise testing; postoperative complications; radical cystectomy

Mesh:

Year:  2015        PMID: 25109512     DOI: 10.1111/bju.12895

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  14 in total

1.  Vigorous intensity aerobic interval exercise in bladder cancer patients prior to radical cystectomy: a feasibility randomised controlled trial.

Authors:  Srijit Banerjee; Kate Manley; Barnabas Shaw; Liane Lewis; Gabriel Cucato; Robert Mills; Mark Rochester; Allan Clark; John M Saxton
Journal:  Support Care Cancer       Date:  2017-11-27       Impact factor: 3.603

2.  Exercise-based pre-habilitation is feasible and effective in radical cystectomy pathways-secondary results from a randomized controlled trial.

Authors:  Bente Thoft Jensen; Sussie Laustsen; Jørgen Bjerggaard Jensen; Michael Borre; Annemette Krintel Petersen
Journal:  Support Care Cancer       Date:  2016-03-10       Impact factor: 3.603

3.  Implementing a Multimodal Prehabilitation Program to Radical Cystectomy in a Comprehensive Cancer Center: A Pilot Study to Assess Feasibility and Outcomes.

Authors:  Bente Thoft Jensen; Jørgen B Jensen; Nora Love-Retinger; Mallory Bowker; Caitlyn Retinger; Guido Dalbagni
Journal:  Urol Nurs       Date:  2019 Nov-Dec

4.  Effectiveness of Perioperative Cardiopulmonary Rehabilitation in Patients With Lung Cancer Undergoing Video-Assisted Thoracic Surgery.

Authors:  Wei-Hao Chao; Sheng-Hui Tuan; En-Kuei Tang; Yi-Ju Tsai; Jing-Hui Chung; Guan-Bo Chen; Ko-Long Lin
Journal:  Front Med (Lausanne)       Date:  2022-06-15

Review 5.  Updates on Robotic Intracorporeal Urinary Diversions.

Authors:  Shawn Dason; Alvin C Goh
Journal:  Curr Urol Rep       Date:  2018-03-15       Impact factor: 3.092

6.  Association of metabolic equivalent of task (MET) score in length of stay in hospital following radical cystectomy with urinary diversion: a multi-institutional study.

Authors:  Chun Shea; Abdul Rouf Khawaja; Khalid Sofi; Ghulam Nabi
Journal:  Int Urol Nephrol       Date:  2021-03-06       Impact factor: 2.370

Review 7.  Role of prehabilitation following major uro-oncologic surgery: a narrative review.

Authors:  Enrico Maria Minnella; Francesco Carli; Wassim Kassouf
Journal:  World J Urol       Date:  2020-10-31       Impact factor: 3.661

Review 8.  How to lower postoperative complications after radical cystectomy - a review.

Authors:  Wojciech Krajewski; Romuald Zdrojowy; Krzysztof Tupikowski; Bartosz Małkiewicz; Anna Kołodziej
Journal:  Cent European J Urol       Date:  2016-11-30

Review 9.  The Preoperative Assessment and Optimization of Patients Undergoing Major Urological Surgery.

Authors:  Helen W Cui; Benjamin W Turney; John Griffiths
Journal:  Curr Urol Rep       Date:  2017-07       Impact factor: 3.092

Review 10.  Preoperative Cardiopulmonary Exercise Test Associated with Postoperative Outcomes in Patients Undergoing Cancer Surgery: A Systematic Review and Meta-Analyses.

Authors:  Daniel Steffens; Hilmy Ismail; Linda Denehy; Paula R Beckenkamp; Michael Solomon; Cherry Koh; Jenna Bartyn; Neil Pillinger
Journal:  Ann Surg Oncol       Date:  2021-06-08       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.